More on AbbVie
- AbbVie: Deep Discount Before Earnings
- AbbVie: “Strong Buy” On Rinvoq Expansions And Immunology Pipeline Addition
- AbbVie: Wins Accumulating While We Wait For Next BD Steps
- AbbVie Non-GAAP EPS of $1.86 beats by $0.08, revenue of $15.78B beats by $200M
- AbbVie Q3 Earnings Preview: R&D charge impact, pipeline progress in focus